Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (Q38348320)

2 September 2017

1 reference

title

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses (English)

1 reference

2 September 2017

0 references

0 references

1 reference

3

1 reference

2 September 2017

4

John P A Ioannidis

1 reference

2 September 2017

Lazaros Belbasis

1

0 references

Ioanna Tzoulaki

series ordinal

5

object named as

Ioanna Tzoulaki

1 reference

2 September 2017

2

Vanesa Bellou

1 reference

PubMed ID

25662901

2 September 2017

language of work or name

1 reference

4 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

14

1 reference

2 September 2017

263-273

1 reference

2 September 2017

3

1 reference

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Incidence and prevalence of multiple sclerosis in the Americas: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Smoking and multiple sclerosis: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

A re-evaluation of random-effects meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

A simple method for converting an odds ratio to effect size for use in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Uncertainty in heterogeneity estimates in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

An exploratory test for an excess of significant findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

On power and sample size for studying features of the relative odds of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Serum uric acid levels in patients with multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The false-positive to false-negative ratio in epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Revised standards for statistical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Meta-analysis of the correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Epstein-Barr virus and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Immunization and MS: a summary of published evidence and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Tetanus vaccination and risk of multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Organic solvents and multiple sclerosis: a synthesis of the current evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Smoking is a risk factor for multiple sclerosis: a metanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Physical trauma and risk of multiple sclerosis: a systematic review and meta-analysis of observational studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Traumatic injury and multiple sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Prolactin in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Meta-analysis of the relationship between homocysteine, vitamin B₁₂, folate, and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Dental amalgam and multiple sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Immunizations and risk of multiple sclerosis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Association between allergies and multiple sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Evaluation of excess significance bias in animal studies of neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Bias in associations of emerging biomarkers with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

1 reference

7 January 2021

Epstein-Barr virus: an important vaccine target for cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The initiation and prevention of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Rituximab for relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Individual and joint action of environmental factors and risk of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Is there a causal link between hepatitis B vaccination and multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

School-based hepatitis B vaccination programme and adolescent multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

Making Prospective Registration of Observational Research a Reality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

The importance of potential studies that have not existed and registration of observational data sets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970267-4

7 January 2021

10.1016/S1474-4422(14)70267-4

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

25662901